1,721,010 research outputs found
Short-term outcome of patients with history of significant coronary artery disease following acute pulmonary embolism
No full text[abstract not available
Should women with endometriosis be screened for coronary artery disease?
No full text[abstract not available
Mathematics and Cardiovascular Interventions: Role of the Finite Element Modeling in Clinical Decision Making
No full text[abstract not available
Mathematics and thrombolysis: Role of the mathematical modelling in understanding and developing blood clot fragmentation
No full textmodelli matematici in medicin
Massive myocardial infarction due to the complete occlusion of the left anterior descending coronary artery after blunt chest trauma
No full textinfarto miocardico massiv
Could advanced drug delivery systems be the future in cardiovascular revascularization medicine?
No full textAcute myocardial infarction, stroke and pulmonary embolism required a prompt revascularization to restore the normal blood flow as soon as possible. Fibrinolytic treatment has gradually become both dated and underused in the treatment of acute myocardial infarction, after the wide diffusion of cathlab and percutaneous transluminal coronary angioplasty. Conversely, the use of systemic thrombolysis remained a benchmark in the treatment of both ischemic stroke and massive pulmonary embolism. In daily clinical practice, the use of thrombolytic agents is often limited by absolute and/or relative contraindications and possible adverse events after the drug administration, as intracranial and/or extracranial bleeding events. To minimize these problems, during the last years, the introduction of nanotechnology in the field of cardiovascular revascularization medicine has created several fascinating results. In the present article, we describe these recent findings and their possible implications in future clinical practice
Game theory and microarray analysis in coronary artery disease and atherosclerosis: Math helps the cardiology research
No full text[abstract not available
Differentiation of cardiac thrombus from cardiac tumor combining cardiac MRI and 18F-FDG-PET/CT Imaging
No full textRadiological differentiation of an unknown cardiac masse is often a challenging issue. 18F-FDG-PET/CT imaging was performed to evaluate a left ventricle mass visualized on transthoracic echocardiogram (TTE) and cardiac magnetic resonance (CMR) in a patient with an history of ischemic heart disease. The metabolically inert area on the PET/CT, corresponding to the relatively homogenous hypodensity in the LV, was thought to represent an old organized LV thrombus. Histopathological examination confirmed the imaging diagnosis
- …
